Hematological abnormalities in liver cirrhosis

Figure 1  Liver-related causes of abnormal hematological parameters in patients with cirrhosis.

Figure 2 Clot formation and lysis sections in rotational thromboelastometry and thromboelastography tracings. Detailed explanation is in Table 1. CT: Clotting time; RT: Reaction time; ROTEM: Rotational thromboelastometry; TEG: Thromboelastography.

Figure 3 Hemostatic balance in patients with chronic liver disease. Created with BioRender.com. TAFI: Thrombin-activatable fibrinolysis inhibitor; tPA: Tissue-plasminogen activator; PAI: Plasminogen activator inhibitor.

Figure 4 Relative risk of venous thromboembolism in patients with cirrhosis vs healthy individuals. Created with BioRender.com. VTE: Venous thromboembolism; PE: Pulmonary embolism; PVT: Portal vein thrombosis; DVT: Deep venous thrombosis; RR: Relative risk.